re: cst and pgl, 2 gravy trains running? I did inform quite a few people when PGL was $1.50 in Jan.
The Options have gone up by 700% or so.
It is a very sophisticated drug, possibly better than AVASTIN.
_________________________
From Pa2000
"The note's from eG Capital.
They comment on Q3 Avastin sales, the relevence for PGL and how conservative their current valuation is (A$6.15).
They highlight as conservative assumptions:
- the deal size (US$100m);
- the drug price (half that of Avastin);
- the royalty rate (8%);
- no value on PI-166;
- no value on Medigen holding;
- no value on other IP (2nd generation PI-88, heparanase products, etc).
The A$16.90 valuation is simply the "unrisked" version (i.e. the drug making it to market) of the A$6.15 one (which discounts royalty revenues by 60% and total valuation by 20% to account for the risk of PI-88 not making it).
Can only imagine what it would look like if they weren't so conservative!"
PA
_____________________
- Forums
- ASX - By Stock
- CST
- cst and pgl: 2 gravy trains running?
cst and pgl: 2 gravy trains running?, page-8
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CST (ASX) to my watchlist
|
|||||
Last
6.8¢ |
Change
0.003(4.62%) |
Mkt cap ! $16.44M |
Open | High | Low | Value | Volume |
6.8¢ | 6.8¢ | 6.8¢ | $2.38K | 35K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 14411 | 6.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.2¢ | 179999 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 14411 | 0.068 |
2 | 58518 | 0.066 |
2 | 145000 | 0.065 |
1 | 50000 | 0.061 |
1 | 50000 | 0.060 |
Price($) | Vol. | No. |
---|---|---|
0.072 | 179999 | 2 |
0.075 | 207566 | 2 |
0.080 | 2500 | 1 |
0.083 | 12000 | 2 |
0.085 | 7000 | 1 |
Last trade - 15.35pm 09/07/2024 (20 minute delay) ? |
Featured News
CST (ASX) Chart |